CureVac and Rentschler Biopharma ramp up vaccine manufacture

The companies aim to produce more than 100 million doses of the CureVac vaccine per year in Laupheim

picture of

Breaking News

Cardinal Health and FourKites partner on cognitive supply chain

FourKites’ work with Cardinal Health began during the onset of the COVID-19 pandemic with a pilot programme

Thermo Fisher and Artificial work to enhance COVID-19 testing platform

As part of the partnership, Thermo Fisher will provide feedback on aLab Suite functionalities and capabilities to ...

Eleva secures up to $74m to advance drug candidate

The company also announced the addition of Dr Ralf Smit to its executive board

Accelerating excipient development for inhalable dosage forms with QbD

Whether they are simply giving an oral dose the bulk it needs to permit handling and swallowing or performing more ...

Vectura earns $11m milestone with Hikma generic launch

The launch of the product follows approval by the US FDA

Orgenesis signs joint venture with Cure Therapeutics

The agreement aims to to advance point-of-care development and commercialisation of cell and gene therapies

Manufacturing Chemist Live: A hybrid event

Taking place on 14-15 September, the event will put delegates ahead of the curve in the global pharmaceutical supply ...

Merck and Artios Pharma announce oncology collaboration

The agreement does not include Artios’s lead programmes, Polθ and ATR inhibitors, for which it will retain all rights

UK government secures an additional 2m Moderna vaccine doses

On October 27, the Medicines and Healthcare products Regulatory Agency started the rolling review process of mRNA-1273 ...

Dissolution development: fast-track methodology for your highly soluble, highly permeable drug

Regarded as a key quality standard, dissolution testing is a powerful tool that’s used to measure a product’s ...

Derisking topical formulation development with multifactorial disease models

Today’s market for topical pharmaceuticals is valued at around $95 billion, with development efforts focused on small ...

The business and patient case for drug delivery device innovation in biosimilar products

Biosimilar development in the United States is at an important juncture, reports Darren Mansell, Regulatory Affairs ...

European Commission purchases 80m vaccine doses from Moderna

The agreement gives the commission the option to purchase an additional 80 million doses up to a total of 160 million

Osivax wins Hello Tomorrow global challenge drug discovery category

The company says its platform could also provide a universal coronavirus vaccine, complementing vaccines currently in ...